CytoMed Therapeutics Limited
GDTCNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $10.34M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.68$3.68
- Volume (live)
- -
- Avg. volume (3M)
- 18.61K
CytoMed Therapeutics (GDTC) Stock Price & Financial Analysis
CytoMed Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.84 - $0.94 |
|---|---|
| 52-Week High | $3.68 |
| 52-Week Low | $0.68 |
| Open | $0.94 |
| Volume (last close) | 7.26K |
| Average Volume (3M) | 18.61K |
| Revenue (TTM) | 520.19K |
|---|---|
| Net Income (TTM) | -4.30M |
| Free Cash Flow (TTM) | -5.63M |
| EPS (TTM) | −$0.36 |
| Profit Margin | -826.34% |
| Operating Margin | -852.79% |
| Return on Equity (ROE) | -110.70% |
| Debt to Equity | 0.09 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 10.34M |
|---|---|
| Shares Outstanding | 11.88M |
| Price to Sales (P/S) | 19.87 |
| Price to Book (P/B) | 2.66 |
| EV/EBITDA | -2.00 |
| 50-Day MA | $0.89 |
|---|---|
| 200-Day MA | $1.00 |
| 1-Year Change | −62.01% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
CytoMed Therapeutics at a Glance
As of the Oct 16, 2026 close, CytoMed Therapeutics (GDTC) has a market capitalization of $10.34M. The stock trades at 19.9× sales. Over the trailing twelve months it lost $4.30M on revenue of $520.19K and burned $5.63M of free cash flow. Revenue grew 44.7% year over year.
As of its latest reported balance sheet, it holds $1.14M in cash and securities against $354.63K of debt, a net cash position of $784.52K.
CytoMed Therapeutics does not currently pay a dividend.
The share price is down 62.0% over the past year. At $0.88 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.68 to $3.68, below its 200-day moving average of $1.00.
Frequently Asked Questions About CytoMed Therapeutics
What is the current stock price for GDTC?
As of the Oct 16, 2026 close, GDTC stock trades at $0.88. The 52-week range is $0.68–$3.68, with a day range of $0.84–$0.94.
What is the P/E ratio for GDTC?
The P/E ratio (Price-to-Earnings) for GDTC is shown in the Key Statistics section. This valuation metric helps compare CytoMed Therapeutics Limited to industry peers.
Does GDTC pay dividends?
CytoMed Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GDTC?
Analyst ratings and recommendations for GDTC are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of GDTC?
As of the Oct 16, 2026 close, CytoMed Therapeutics's market capitalization is $10.5M, classifying it as a micro-cap company. CytoMed Therapeutics operates in the Healthcare sector within the Biotechnology industry.